Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NPCE NASDAQ:OM NASDAQ:TMCI NASDAQ:ZJYL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNPCENeuroPace$9.50+1.6%$12.05$5.45▼$18.98$306.67M1.93188,784 shs200,988 shsOMOutset Medical$19.44+2.6%$19.37$5.85▼$62.10$335.84M2.15159,163 shs393,988 shsTMCITreace Medical Concepts$6.08+3.2%$5.95$4.54▼$10.79$370.42M0.69483,633 shs250,989 shsZJYLJin Medical International$0.70+9.2%$0.70$0.50▼$4.38$100.33M9.85282,457 shs329,126 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNPCENeuroPace+1.60%+4.28%-10.12%-15.56%+12.29%OMOutset Medical+2.59%+7.40%+11.92%+79.01%-68.16%TMCITreace Medical Concepts+3.23%+3.93%+5.92%-8.71%-24.38%ZJYLJin Medical International+9.16%+9.52%+8.40%-18.65%-80.46%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNPCENeuroPace3.3503 of 5 stars3.53.00.00.00.04.20.6OMOutset Medical1.7826 of 5 stars3.51.00.00.03.20.80.0TMCITreace Medical Concepts2.1259 of 5 stars3.22.00.00.00.63.30.6ZJYLJin Medical InternationalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNPCENeuroPace 3.00Buy$17.0078.95% UpsideOMOutset Medical 3.00Buy$29.5051.75% UpsideTMCITreace Medical Concepts 2.33Hold$10.5272.97% UpsideZJYLJin Medical International 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ZJYL, TMCI, NPCE, and OM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/14/2025OMOutset MedicalBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$37.005/28/2025NPCENeuroPaceHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$18.005/21/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSector Perform ➝ Sector Perform$14.00 ➝ $21.005/15/2025OMOutset MedicalScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/14/2025NPCENeuroPaceJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$14.00 ➝ $16.005/14/2025NPCENeuroPaceCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$17.00 ➝ $17.005/9/2025TMCITreace Medical ConceptsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$10.00 ➝ $8.605/8/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$12.00 ➝ $14.00(Data available from 7/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNPCENeuroPace$79.91M3.90N/AN/A$0.27 per share35.19OMOutset Medical$113.69M3.03N/AN/A$7.49 per share2.60TMCITreace Medical Concepts$209.36M1.83N/AN/A$1.81 per share3.36ZJYLJin Medical International$23.50M4.66$0.03 per share25.38$0.18 per share3.89Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNPCENeuroPace-$27.14M-$0.84N/AN/AN/A-29.42%-190.84%-25.08%8/12/2025 (Estimated)OMOutset Medical-$127.98M-$29.15N/A∞N/A-98.74%-143.62%-37.50%8/6/2025 (Estimated)TMCITreace Medical Concepts-$55.74M-$0.85N/AN/AN/A-25.14%-48.69%-24.59%8/5/2025 (Estimated)ZJYLJin Medical International$3.68MN/A0.00∞N/AN/AN/AN/AN/ALatest ZJYL, TMCI, NPCE, and OM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025NPCENeuroPace-$0.24N/AN/AN/A$23.08 millionN/A8/6/2025Q2 2025OMOutset Medical-$1.76N/AN/AN/A$29.40 millionN/A8/5/2025Q2 2025TMCITreace Medical Concepts-$0.28N/AN/AN/A$47.08 millionN/A5/13/2025Q1 2025NPCENeuroPace-$0.26-$0.21+$0.05-$0.21$21.85 million$22.52 million5/8/2025Q1 2025TMCITreace Medical Concepts-$0.31-$0.25+$0.06-$0.25$52.07 million$52.57 million5/7/2025Q1 2025OMOutset Medical-$0.97-$3.66-$2.69-$3.66$27.81 million$29.75 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNPCENeuroPaceN/AN/AN/AN/AN/AOMOutset MedicalN/AN/AN/AN/AN/ATMCITreace Medical ConceptsN/AN/AN/AN/AN/AZJYLJin Medical InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNPCENeuroPace2.466.635.70OMOutset Medical0.578.376.74TMCITreace Medical Concepts0.514.503.36ZJYLJin Medical InternationalN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNPCENeuroPace78.83%OMOutset MedicalN/ATMCITreace Medical Concepts84.08%ZJYLJin Medical InternationalN/AInsider OwnershipCompanyInsider OwnershipNPCENeuroPace20.50%OMOutset Medical2.40%TMCITreace Medical Concepts27.72%ZJYLJin Medical InternationalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNPCENeuroPace17032.80 million26.08 millionOptionableOMOutset Medical52017.72 million17.30 millionNot OptionableTMCITreace Medical Concepts25062.89 million45.46 millionOptionableZJYLJin Medical International245156.55 millionN/ANot OptionableZJYL, TMCI, NPCE, and OM HeadlinesRecent News About These CompaniesJin Medical International Ltd. Launches Production at New Intelligent Manufacturing Facility in Anhui, ChinaJuly 15, 2025 | quiverquant.comQJin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing FacilityJuly 15, 2025 | globenewswire.comJin Medical International (NASDAQ:ZJYL) Trading Up 2.7% - Should You Buy?July 10, 2025 | marketbeat.comJin Medical Faces Nasdaq Listing Compliance ChallengeMay 6, 2025 | tipranks.comJin Medical International Ltd. -- Nasdaq Minimum Bid Price Non-ComplianceMay 6, 2025 | gurufocus.comJin Medical International Ltd. – Nasdaq Minimum Bid Price Non-ComplianceMay 6, 2025 | globenewswire.comIs Jin Medical International Ltd.'s (NASDAQ:ZJYL) Recent Stock Performance Influenced By Its Fundamentals In Any Way?April 28, 2025 | finance.yahoo.comJin Medical Boosts Production Capacity with New Chuzhou FacilityApril 25, 2025 | tipranks.comJIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)April 13, 2025 | nasdaq.comWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Down 12.45%April 3, 2025 | aaii.comAWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Up 10.09%March 25, 2025 | aaii.comAWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Down 29.03%March 21, 2025 | aaii.comAWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Up 14.61%March 20, 2025 | aaii.comAWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Up 11.29%January 31, 2025 | aaii.comAJin Medical International Full Year 2024 Earnings: EPS: US$0.023 (vs US$0.02 in FY 2023)January 27, 2025 | finance.yahoo.comWuhan Jin Jiang International HotelNovember 12, 2024 | travelweekly.comTJin of BTS fronts rock band in 'I'll Be There' music videoOctober 25, 2024 | msn.comConstruction of JinMed's New Facility Begins in Chuzhou, ChinaOctober 10, 2024 | globenewswire.comSome Investors May Be Worried About Jin Medical International's (NASDAQ:ZJYL) Returns On CapitalOctober 9, 2024 | finance.yahoo.comZJYL Sees a Stock Surge of 5.04% Amid Positive Financial PerformanceOctober 2, 2024 | gurufocus.comCrude Oil Down Over 1%; US Manufacturing PMI Falls In SeptemberSeptember 24, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeZJYL, TMCI, NPCE, and OM Company DescriptionsNeuroPace NASDAQ:NPCE$9.50 +0.15 (+1.60%) Closing price 07/23/2025 04:00 PM EasternExtended Trading$9.60 +0.11 (+1.11%) As of 08:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.Outset Medical NASDAQ:OM$19.44 +0.49 (+2.59%) Closing price 07/23/2025 04:00 PM EasternExtended Trading$18.73 -0.72 (-3.68%) As of 08:38 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.Treace Medical Concepts NASDAQ:TMCI$6.08 +0.19 (+3.23%) Closing price 07/23/2025 04:00 PM EasternExtended Trading$6.08 0.00 (-0.08%) As of 07/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.Jin Medical International NASDAQ:ZJYL$0.70 +0.06 (+9.16%) Closing price 07/23/2025 03:59 PM EasternExtended Trading$0.70 0.00 (-0.09%) As of 08:33 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Former Dividend Aristocrat AT&T a Buy After Q2 Earnings? What's Behind Opendoor Technologies' Rally? Is Meme Mania Back? The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying The Bottom Is in for Kohl’s, But Let the Share Price Come to You Rocket Lab: A Parabolic Run Meets a Healthy Pullback Intuitive Surgical Crushes Q2 Expectations, So Why No Rally? Why Meta’s AI Titan Clusters Are a Game-Changer for Broadcom Kratos Defense Is Changing Warfare—Here’s What’s Driving It Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
